SIBN (SI-BONE) Other Current Receivables: $0.6 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SIBN SI-BONE Inc SIBN
78 GF Score
Price $17.38
GF Value $20.50
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is SI-BONE Other Current Receivables?

SI-BONE SIBN -1.86% 78 Other Current Receivables is $0.6 Mil as of Mar. 2026. GuruFocus rates SIBN with a GF Score™ of 78/100 and a GF Value™ of $20.50 (Modestly Undervalued). The stock has 3 warning signs investors should review.

SI-BONE's Other Current Receivables for the quarter that ended in Mar. 2026 was $0.6 Mil.

SI-BONE's quarterly Other Current Receivables stayed the same from Sep. 2025 ($0.00 Mil) to Dec. 2025 ($0.00 Mil) but then increased from Dec. 2025 ($0.00 Mil) to Mar. 2026 ($0.60 Mil).

SI-BONE Other Current Receivables Related Terms

SI-BONE Other Current Receivables Historical Data

* Premium members only.

The historical data trend for SI-BONE's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SI-BONE Other Current Receivables Chart

SI-BONE Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

SI-BONE Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.60
SIBN
78GF Score
SI-BONE Inc SIBN
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SI-BONE Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of $0.6 Mil mean?
SI-BONE (SIBN) has a Other Current Receivables of $0.6 Mil as of Mar. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on SI-BONE and its competitors.
Is SI-BONE's Other Current Receivables too high?
SI-BONE's current Other Current Receivables is $0.6 Mil. Overall, SI-BONE has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does SI-BONE's Other Current Receivables compare to CBLL and BBNX?
SI-BONE's Other Current Receivables of $0.6 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Medical Devices & Instruments company?
A good Other Current Receivables depends on the Medical Devices & Instruments industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on SI-BONE and its competitors. SI-BONE's current Other Current Receivables is $0.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SI-BONE stock overvalued right now?
Based on GuruFocus' analysis, SI-BONE (SIBN) is currently considered Modestly Undervalued. The stock's GF Value™ is $20.50, compared to a current price of $17.38 — trading 15.2% below its estimated fair value. The current Other Current Receivables is $0.6 Mil. SI-BONE's overall GF Score™ is 78/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For SI-BONE (SIBN), the current Other Current Receivables is $0.6 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SI-BONE (SIBN) Overvalued in 2026?

Based on GuruFocus' analysis, SI-BONE stock appears to be undervalued. The current stock price of $17.38 is trading 15.2% below its estimated GF Value™ of $20.50. GuruFocus considers SI-BONE to be Modestly Undervalued.

Key valuation signals for SIBN:

  • Other Current Receivables: $0.6 Mil
  • GF Value™: $20.50 vs. price of $17.38 (15.2% below fair value)
  • GF Score™: 78/100 with 3 warning signs

No single metric tells the full story. See the SIBN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SI-BONE Business Description

Other Exchanges 2K3:Germany
Address 471 El Camino Real, Suite 101, Santa Clara, CA, USA, 95050
SI-BONE Inc is a medical device company that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite, which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
78GF Score

Get the complete analysis for SIBN

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$17.38
Price
$20.50
GF Value